Antitrust Issues in the Life Sciences Product Cycle

San Diego Presentation


San Diego, CA
Kelly Stuart
(202) 778-1655

Antitrust Issues in Life Sciences Industries under the New Administration

  • Strategic Transactions: Impact of Antitrust on Options, Licenses, Partnering, M&A (HSR Process, Timeline, and Impact on Structuring)
  • Building and Extending the Franchise: Antitrust Issues in Sales and Life Cycle Management Strategies (Bundled Discounts, Pricing, Product Switching, etc.)
  • Attacking and Defending the Franchise: Antitrust Issues in IP Litigation and Settlement

Senior management of life sciences companies, as well as legal, finance, and business development professionals at all levels; life sciences investors.

Sean Gates
Jeffrey Jaeckel
David L. Meyer
Laura O. Spiegelman
Mark R. Wicker

Morrison & Foerster LLP (Provider #2183) certifies that this activity has been approved for MCLE credit by the State of California in the amount of 1 hour.




Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.